This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Caiping Tian
Introduction
Caiping Tian is a notable inventor based in Nanjing, China. He has made significant contributions to the field of cancer research through his innovative work on peptides. His research focuses on developing targeted therapies that can improve cancer diagnosis and treatment.
Latest Patents
Caiping Tian holds a patent for a pentapeptide associated with integrin receptor αvβ3. This pentapeptide has a specific sequence of arginine-tryptophan-arginine-asparagine-methionine. It is designed to target tumor cells that highly express the αvβ3 receptor, while sparing those that express it at lower levels and normal cells. This specificity makes the pentapeptide a valuable tool in the diagnosis and treatment of various cancers. He has 1 patent to his name.
Career Highlights
Caiping Tian is affiliated with China Pharmaceutical University, where he conducts his research. His work has garnered attention for its potential applications in oncology. His innovative approach to peptide design showcases his commitment to advancing medical science.
Collaborations
Caiping Tian collaborates with esteemed colleagues, including Yueqing Gu and Congying Zhang. Their combined expertise enhances the research efforts in the field of cancer treatment.
Conclusion
Caiping Tian's contributions to cancer research through his innovative peptide patent highlight the importance of targeted therapies in modern medicine. His work continues to pave the way for advancements in cancer diagnosis and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile